EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
Since the January 2015 Board Meeting…
2015 COST application
EAHP prepared and submitted a second submission to the EU’s COST programme to fund an international research network on the topic of medicines shortages.
Taking on board comments received from assessors in 2014 a focus was given to improving the spread of interested parties in the network of ‘secondary proposers’ with 54 secondary proposers representing 25 countries from Europe, North America and Near Neighbouring Countries, including a spread of pharmacist organisations (e.g. EAHP, EIPG, ESOP, FIP, ASHP, Canadian hospital pharmacists, EAFP), other healthcare professional organisations (e.g. haematologists, respiratory specialists, CPME), patient organisations (rare disease patients, EPHA, EHN, European Patients Forum, European Cancer Patient Coalition, European Multiple Sclerosis Platform, AGE Platform Europe, European AIDS Treatment Group), and other organisations and representatives including ethicists, social scientists, lawyers, HOPE and the Drug Information Association.
Despite repeated invitations, PGEU, EFPIA, EGA, EAHP’s corporate partners, ESCP, GIRP, AESGP and EAEPC declined to be involved at the point of application.
The application will now be reviewed by the COST office and following a number of stages of review we may be invited to a panel interview in September. The final submission is available to view here. Names of secondary proposers here.
In any case, with such an interested network coming together for the submission, there is a suggestion that we maintain and make use of the enthusiasm on an ad hoc basis e.g. semi-regular updates sent out with shortages-related news.
Continued interest in the November 2014 Report
Elsewhere, media interest in the November 2014 report continues with the Lancet recently publishing an article inspired by the report. Available here.
The President was also recently invited to present the results at a Drug Information Association conference in Paris.
Politically, a meeting between EAHP, EURORDIS (rare disease patients’ association) and the Latvian Presidency of the European Union is scheduled to take place shortly to consider whether a medicines shortages item could be added to the agenda of the June 2015 meeting of EU Health Ministers.
Work also continues with the “supply chain stakeholders” (EFPIA, EGA, GIRP, EAEPC, AESGP, PGEU and EAHP). EAHP recently gave its response the European Commission’s Matrix Insight Study (published in December 2014 two years after it was completed!) with an intention that the supply chain stakeholders give a joint response.
John Chave has also invited the stakeholder organisations to contribute their views on matters relating to medicines shortages information. More information here.
Regrettably the supply chain stakeholders held a meeting on shortages information examining some potential national best practise case studies at a time when EAHP could not participate (during the EAHP Congress). A catch up telephone call with John Chave will take place on his return from vacation next week.
Finally, EAHP held an off programme meeting at the EAHP Congress on medicines shortages information provision which is intended to form the basis of a short paper that can be shared publicly as a contribution to the overall discussion.
